guest ::
| Home > Publications Database > Use of advanced neuroimaging and artificial intelligence in meningiomas. |
| Home > Publications Database > Use of advanced neuroimaging and artificial intelligence in meningiomas. |
| Journal Article (Review Article) | DZNE-2022-00023 |
; ; ; ; ; ; ;
2022
Wiley-Blackwell
Oxford
This record in other databases: 
Please use a persistent id in citations: doi:10.1111/bpa.13015
Abstract: Anatomical cross-sectional imaging methods such as contrast-enhanced MRI and CT are the standard for the delineation, treatment planning, and follow-up of patients with meningioma. Besides, advanced neuroimaging is increasingly used to non-invasively provide detailed insights into the molecular and metabolic features of meningiomas. These techniques are usually based on MRI, e.g., perfusion-weighted imaging, diffusion-weighted imaging, MR spectroscopy, and positron emission tomography. Furthermore, artificial intelligence methods such as radiomics offer the potential to extract quantitative imaging features from routinely acquired anatomical MRI and CT scans and advanced imaging techniques. This allows the linking of imaging phenotypes to meningioma characteristics, e.g., the molecular-genetic profile. Here, we review several diagnostic applications and future directions of these advanced neuroimaging techniques, including radiomics in preclinical models and patients with meningioma.
Keyword(s): Artificial Intelligence (MeSH) ; Humans (MeSH) ; Meningeal Neoplasms: diagnostic imaging (MeSH) ; Meningioma: diagnostic imaging (MeSH) ; Neuroimaging (MeSH) ; Positron-Emission Tomography (MeSH) ; MRI ; PET ; radiogenomics ; radiomics
; 
; 
; 
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF
PDF (PDFA)